Introduction to special issue on "Nanoparticles in Medicine: Targeting, Optimization and Clinical Applications"
The precise delivery of therapeutic molecules and imaging agents to diseased tissues via rationally designed nanoparticles has offered a great promise and a challenge at the same time. Since the launch in 2005 of the Cancer Nanotechnology initiative from the National Cancer Institute, an incredibly large number of scientific manuscripts have been published on the use of nanoparticles for drug delivery and imaging. A quick PubMed search on "cancer" and "nanoparticles" would return over 15,000 articles published over the past two decades. Even more remarkable is the number of nanoformulated drugs that have entered the clinical trials: about 40 "nanomedicines" are currently under screening at different levels of clinical trials and several more are in the pipeline, and it is hoped that some of these will reach the clinic within the next few years. Given that the devel- This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
